e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A global strategy for tuberculosis research and innovation
Nebiat Gebreselassie, Tereza Kasaeva, Matteo Zignol
Source:
Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nebiat Gebreselassie, Tereza Kasaeva, Matteo Zignol. A global strategy for tuberculosis research and innovation. Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018
The effectiveness of the national program tuberculosis control in Ukraine and the future strategy
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006
Using a rapid prioritisation process to identify health research priorities in LMICs
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
Scaling-up global implementation of LTBI management: a paradigm shift needed
Source: International Congress 2016 – ERS and tuberculosis
Year: 2016
New experiences from global use of new tools in TB management and control
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013
TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
The impact of digital health technologies on tuberculosis treatment: a systematic review
Source: Eur Respir J, 51 (1) 1701596; 10.1183/13993003.01596-2017
Year: 2018
Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Year: 2020
Tuberculosis research questions identified through the WHO policy guideline development process
Source: Eur Respir J, 53 (3) 1802407; 10.1183/13993003.02407-2018
Year: 2019
Crowdfunding for respiratory research: a new frontier for patient and public engagement?
Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017
Year: 2017
A cost optimization approach to occupational health screening for tuberculosis
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Childhood tuberculosis: progress requires an advocacy strategy now
Source: Eur Respir J 2012; 40: 294-297
Year: 2012
Tuberculosis prevention must integrate technological and basic care innovation
Source: Eur Respir J 2016; 48: 1531-1532
Year: 2016
The exposome concept: a challenge and a potential driver for environmental health research
Source: Eur Respir Rev 2016; 25: 124-129
Year: 2016
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Advancing global programmatic management of latent tuberculosis infection for at risk populations
Source: Eur Respir J 2016; 47:1327-1330
Year: 2016
How to optimise patient and public involvement in your research: Doing science
Source: Breathe 2015; 11:223-227
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept